# Evaluate Recovery of Testosterone for Patients Using Eligard

> **NCT01136226** · PHASE4 · COMPLETED · sponsor: **Chesapeake Urology Research Associates** · enrollment: 42 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Eligard (TM)

## Key facts

- **NCT ID:** NCT01136226
- **Lead sponsor:** Chesapeake Urology Research Associates
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2018-10-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01136226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01136226, "Evaluate Recovery of Testosterone for Patients Using Eligard". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01136226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*